Shandong Xinhua Pharmaceutical Co Ltd (000756) - Total Liabilities

Latest as of June 2025: CN¥3.87 Billion CNY ≈ $566.69 Million USD

Based on the latest financial reports, Shandong Xinhua Pharmaceutical Co Ltd (000756) has total liabilities worth CN¥3.87 Billion CNY (≈ $566.69 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Shandong Xinhua Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Shandong Xinhua Pharmaceutical Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Shandong Xinhua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 000756 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Shandong Xinhua Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shandong Xinhua Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Monex S.A.B. de C.V MX:MONEXB	Mexico	MX$190.09 Billion
Wereldhave NV AS:WHA	Netherlands	€1.30 Billion
Tejas Networks Limited NSE:TEJASNET	India	Rs65.60 Billion
Vivenio Residencial SOCIMI S.A. MC:YVIV	Spain	€516.27 Million
Shenzhen Shenbao Industrial Co Ltd SHE:000019	China	CN¥2.02 Billion
Bank Tabungan Negara Persero JK:BBTN	Indonesia	Rp480.77 Trillion
Sivers IMA Holding AB ST:SIVE	Sweden	Skr374.60 Million
Univest Corporation Pennsylvania NASDAQ:UVSP	USA	$7.49 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Shandong Xinhua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 000756 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.76	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Xinhua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)

The table below shows the annual total liabilities of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.80 Billion ≈ $556.37 Million	+8.31%
2023-12-31	CN¥3.51 Billion ≈ $513.68 Million	-10.34%
2022-12-31	CN¥3.92 Billion ≈ $572.92 Million	+6.37%
2021-12-31	CN¥3.68 Billion ≈ $538.63 Million	-0.56%
2020-12-31	CN¥3.70 Billion ≈ $541.67 Million	+11.31%
2019-12-31	CN¥3.33 Billion ≈ $486.62 Million	+6.60%
2018-12-31	CN¥3.12 Billion ≈ $456.50 Million	+15.79%
2017-12-31	CN¥2.69 Billion ≈ $394.25 Million	+1.92%
2016-12-31	CN¥2.64 Billion ≈ $386.82 Million	+5.40%
2015-12-31	CN¥2.51 Billion ≈ $367.01 Million	--

About Shandong Xinhua Pharmaceutical Co Ltd

SHE:000756 China Drug Manufacturers - Specialty & Generic

Market Cap

$995.52 Million

CN¥6.80 Billion CNY

Market Cap Rank

#8829 Global

#2109 in China

Share Price

CN¥13.75

Change (1 day)

+1.55%

52-Week Range

CN¥11.95 - CN¥18.15

All Time High

CN¥44.80